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ABSTRAK
Dewasa muda yang mengalami kejadian jantung akut (acute cardiac event) seperti sindrom koroner akut, 
aritmia yang terkait dengan iskemia dan kematian mendadak, seringkali tidak diketahui penyebabnya dan juga 
tidak mempunyai faktor risiko yang bermakna. Vaskulitis koroner akibat penyakit Kawasaki turut berperan 
sebagai faktor risiko pada populasi dewasa muda dan menimbulkan kejadian koroner akut. Penyakit Kawasaki 
terutama menyerang di masa kanak-kanak, menyebabkan vaskulitis arteri koroner dan hal ini menjadi perhatian 
utama karena menimbulkan aneurisma dan stenosis di kemudian hari. Penyakit Kawasaki bersifat swa-sirna atau 
dapat sembuh dengan sendirinya, sehingga penderita penyakit ini di masa kanak-kanak dapat bertahan hingga 
masa dewasa. Bertambah cepatnya proses aterosklerosis koroner yang terjadi pada lesi yang terkait dengan 
penyakit Kawasaki pada dewasa muda serta sindrom koroner akut dan kematian mendadak yang menyertai 
pada populasi ini merupakan dampak buruk dan gejala sisa yang sangat memprihatinkan dari penyakit ini. 
Diharapkan, para ahli penyakit dalam dan kardiologi dewasa dapat mengenali gejala sisa ini dan menyediakan 
layanan yang lebih baik bagi para pasien. 
Kata kunci: penyakit Kawasaki, aneurisma koroner, aterosklerosis.
ABSTRACT
Young adults suffered from acute cardiac event, such as acute coronary syndrome, ischemic-associated 
arrhythmia and sudden death, are frequently encountered without known etiology and significant risk factors. 
Coronary vasculitis due to Kawasaki disease contributes to be a risk factor in young adult population to develop 
acute coronary event. Afflicted predominantly during childhood, Kawasaki disease gives rise to vasculitis of 
coronary artery which becomes major concern since it leads to coronary aneurysm and stenosis. Self-limited 
nature of Kawasaki disease make those suffered in childhood survive into adult life. Accelerated coronary 
atherosclerosis in the Kawasaki disease-related lesion occurring in young adult and subsequent acute coronary 
syndrome and sudden death in this population are devastating impacts of the sequel of Kawasaki disease. It 
is expected that internists and adult cardiologists become familiar with this sequel and provide better care for 
the patients.
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INTRODUCTION
Doctor Tomisaku Kawasaki, a Japanese 
pediatrician, first reported the new syndrome 
occurring in 50 Japanese children between 
1961 and 1967.1 This syndrome is known as 
Kawasaki disease or Kawasaki syndrome.1 
Kawasaki disease currently becomes the most 
common acquired heart disease in children 
among developed countries, especially in Japan, 
where its incidence is ten times higher than it is 
in Western countries.2 There is a predilection 
towards Asian population, although the syndrome 
occurs in all other races as well.3,4
Initially, this disease is thought to be a 
pediatric problem, because its self-limited nature. 
After populational study involving long term 
follow-up of children affected with Kawasaki 
disease, the natural history of this disease 
becomes apparent that it will cause sequel in adult 
life.2,3 The natural history of Kawasaki disease 
before the era of intravenous immunoglobulin 
is as follows: 1) approximately 20%-25% of 
children developed coronary artery aneurysms as 
a sequel of coronary artery vasculitis, (2) patients 
who developed coronary artery aneurysms during 
acute phase, 20% will progress to coronary 
artery stenosis and (3) myocardial ischemia 
and infarction, even sudden cardiac death, is 
potentially occur in relatively young age, which 
need treatment such as percutaneous coronary 
intervention, coronary artery bypass grafting, 
and even cardiac transplantation.3
As children with acute phase of Kawasaki 
disease mostly survived, the sequel of coronary 
lesion will develop in adult life. Accelerated 
coronary atherosclerosis occurring in relatively 
young age is contributed mainly by Kawasaki 
disease sequel, which leads to acute coronary 
syndrome and sudden death in this population. 
While pediatricians care children with acute 
phase of Kawasaki disease, internists and adult 
cardiologists may care these patients in adult 
life. Sometimes their childhood medical history 
of Kawasaki disease was not documented, even 
undiagnosed. Thus, understanding the sequel of 
this disease in adult life is of paramount important 
for internists and adult cardiologists. This review 
provides an information regarding sequel of 
Kawasaki disease which affect coronary artery 
in adult life.
KAWASAKI DISEASE IN CHILDHOOD
Kawasaki disease is an acute systemic 
inflammatory disease involving multiple organs 
and tissues, with coronary artery vasculitis is the 
most clinically significant feature.4 This disease 
is a self-limited syndrome.3-5 Kawasaki disease 
developed over first ten days of febrile illness and 
than steadily disappear in most children, even 
without specific therapy.6
Children with age between 6 months and 5 
years were predominate age groups susceptible 
for Kawasaki disease.3,5,6
Fever for at least five days’ duration, with at 
least four of the following five clinical features: 
1). polymorphous exanthema (but not petechial, 
bullous, or vesicular lesions); 2). bilateral non-
exudative conjunctival injection; 3). changes in 
lips and oral cavity (but not discrete oral lesions 
or exudates); 4). changes in the extremities, 
including erythema or indurative oedema, and 
later (in the second week of illness) membranous 
desquamation starting around the nail bed; 
5). cervical lymphadenopathy, often unilateral 
and large.
Children who meet the above criteria are 
diagnosed with complete Kawasaki disease. Since 
there is no specific diagnostic tool for Kawasaki 
disease, clinical diagnostic criteria must be 
examined carefully to avoid misdiagnosis.
Incomplete or atypical form of Kawasaki 
disease is diagnosed if children in suspicion do 
not meet the above criteria. This term is used 
for children with fever at least five days and 
at least two of the above criteria without other 
explainable illness and laboratory examination 
revealed systemic inflammation (high level of 
C reactive protein or erythrocyte sedimentation 
rate).6 Incomplete (atypical) Kawasaki disease 
often suffers from coronary artery abnormality 
seen on echocardiography.5,6
Along with clinical features which appear 
sequentially, laboratory examination reveals 
following features during 7-10 days of disease:6 
1). rutin haematology: elevated leukocyte 
count with neutrophilia (at least 50% of cases), 
progressive anaemia (usually normocytic and 
normochromic), increased platelet count (peak in 
the second or third week of illness).  2). urinalysis: 
urinary sediment may contain increased numbers 
of leukocytes without bacteruria; 3). acute phase 
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proteins: elevated C reactive protein (>35mg/l 
in 80%of cases), erythrocyte sedimentation rate 
(>60 mm/h in 60% of cases); 4). blood chemistry: 
low serum sodium, low serum protein and 
albumin, elevated liver enzymes (specifically 
alanine aminotranferase), and abnormal blood 
lipid profile; 5). cerebrospinal fluid: pleocytosis, 
usually lymphocytic with normal protein and 
glucose.
Systemic vasculitis frequently developed 
in Kawasaki disease, with coronary artery can 
be severely affected. Thus cardiac examination 
must be completed as part of examination. 
Electrocardiography and echocardiography 
examinations are mandatory.6
Electrocardiography. Sinus tachycardia with 
decreased QRS voltages, flattened T waves, 
and prolonged QTc intervals. These features 
are almost always reversible. Heart block 
may occur. In untreated large coronary artery 
aneurysms, electrocardiography may show signs 
of myocardial infarction as a result of coronary 
thrombosis.
Echocardiography. Decreased left ventricular 
function, mitral regurgitation, and pericardial 
effusion may be seen. Coronary artery dilatation 
could be observed starting an average of 9-10 
days after onset of fever and occurs in 30-50% 
of cases.
Cardiac  involvement  const i tu te  of 
myocarditis, pericarditis with pericardial effusion 
and valvulitis. Pericarditis and small pericardial 
effusions will resolve spontaneously without 
sequel in almost all of the patients.7 Valvulitis in 
acute phase of Kawasaki disease develops in  2% 
of patients, most commonly in the mitral valve 
which will become scarring and  incompetence.8 
Early myocardial involvement always resolves 
completely and does not necessarily associate 
with coronary artery involvement. Long-term 
myocardial contractility and function measured 
by echocardiography is normal.9
KAWASAKI DISEASE IN ADULTHOOD
Kawasaki disease is rarely seen in infant aged 
less than 6 months and in adults, which supports 
the existence of an infectious agent for which 
maternal immunity is protective during infant and 
protective immunity development during adult 
life.10 Although very rare, several case reports 
showed that acute phase of Kawasaki disease 
occurred in adult patients.11 Similar to that in 
children, no specific diagnostic tool is available 
for acute Kawasaki disease in adulthood, thus 
clinician relies on meticulous findings of clinical 
diagnostic criteria.
Kawasaki disease in adulthood mimics several 
diseases with fever, cutaneous rash, mucosal 
involvement and cervical lymphadenopathy, 
such as scarlet fever, Still's disease, systemic 
lupus erythematosus, meningococcemia, 
staphylococcal scalded-skin syndrome, Stevens-
Johnson syndrome, and several viral rash fever.11 
The clinical diagnostic criteria for Kawasaki 
disease in adulthood are similar to those of in 
the children. The presence of coronary artery 
aneurysm and sequel after acute Kawasaki 
disease in adulthood are unknown, since long 
term follow-up data unavailable.
TREATMENT OF KAWASAKI DISEASE
Intravenous Immunoglobulin
Randomized controlled trials have shown 
that a single infusion of 2 g/kg of intravenous 
immunoglobulin given 5-10 days after the onset 
of fever eliminates fever in 85-90% of children 
within 36 hours and significantly reduces the 
risk of coronary artery aneurysms.12 Reduction 
of coronary artery aneurysm was achieved until 
3.8% after the use of high-dose immunoglobulin 
therapy.13
Aspirin
Aspirin has been used in the treatment of 
Kawasaki disease due to its antiinflammatory 
effect at high doses and antiplatelet effect at low 
dose, however it does not decrease the incidence 
of coronary artery coronary abnormalities.12 
During the acute phase of disease, aspirin is 
given at a dose 30 to 50 mg/kg divided into three 
doses afterward followed by 3 to 5 mg/kg once 
daily after recovery.13  This combination has an 
additive antiinflammatory effect.12 For children 
in whom aneurysms of the coronary arteries have 
been diagnosed, aspirin in an antiplatelet dose is 
continued on a daily basis as long as aneurysms 
persist and echocardiography examination is 
needed to evaluate the aneurysms.5,9 The goal 
of this therapy is to prevent thrombosis and the 
myointimal proliferation that leads to coronary 
stenosis.14
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Corticosteroids
Before the era of intravenous immunoglobulin, 
a high incidence of coronary artery aneurysms 
was encountered in children with Kawasaki 
disease treated with corticosteroids as primary 
therapy. Randomized, controlled studies showed 
conflicting results of the use of corticosteroids for 
the primary treatment of Kawasaki disease.13 Pulse 
corticosteroid did not add beneficial effect beyond 
standard therapy, i.e intravenous immunoglobulin 
and aspirin15, however, methylprednisolon 30 mg/
kg daily for 3 days is recommended if there is 
no response to the second cycle of intravenous 
immunoglobulin infusion.6 In contrast to other 
systemic vasculitis, which usually respond to 
corticosteroids, Kawasaki disease vasculitis did 
not response well with corticosteroid.15
CORONARY ANEURYSMS IN KAWASAKI 
DISEASE
The incidence of coronary aneurysm as 
a sequel of Kawasaki disease was 16.7% in 
year of 1983, at the time before intravenous 
immunoglobulin given as standard treatment, and 
was rapidly decreased to 3.8% in 2007 as the use of 
high-dose immnunoglobulin therapy emerging.13
Mild diffuse dilatation of coronary arteries 
arises in 30-50% of acute Kawasaki disease 
children and begins approximately ten days from 
onset of febrile illness.12,16 In the majority of 
cases, this mild dilatation is transitory and will 
regress within six to eight weeks of febrile onset9, 
the term called transient coronary dilatation.13 
Persistent coronary aneurysms in the recovery 
phase or afterward are considered sequel 
of Kawasaki disease.12,13 Echocardiography 
examination during this time is an important tool 
to assess the coronary lesion and follow-up until 
recovery phase, around 30 day, is necessary for 
those with coronary lesion.13
Coronary artery vasculitis occurs during acute 
Kawasaki disease which features as endothelial 
cell swelling and subendothelial edema as well 
as mononuclear cells infiltration in coronary 
wall.17 Internal elastic lamina is subsequently 
disrupted and myointimal proliferation within 
discrete area occurs.17 Medial layer release matrix 
metalloprotease and vascular smooth muscle 
cell become necrotic and replace by fibrosis 
and calcification.18 Imbalance between matrix 
metaloprotease and its tissue inhibitor may cause 
excessive fibrosis and aneurysms.19
Coronary aneurysms in Kawasaki disease 
can be divided based on its diameter:13 (1) 
small aneurysms (internal diameter ≤4 mm), 
(2) medium aneurysms (internal diameter 4–8 
mm) and (3) giant aneurysms (internal diameter 
>8 mm). Small aneurysms tend to undergo 
resolution and rarely progress to stenotic or 
thrombotic lesions.19 Meanwhile, medium and 
giant aneurysms associated with thrombus 
occlusion on aneurysm site and even rupture of 
aneurysms, although wide range of remodeling 
processes occurs.13,20
In the late acute phase and early recovery 
phase of Kawasaki disease, coronary artery 
lesions undergo dynamic alteration and wide 
range of remodeling.2,13,20 The prognosis of 
coronary artery aneurysms from Kawasaki 
disease is as follows: (1) Regression: regression 
of coronary artery aneurysms has been reported 
to occur in 50% to 67% of vessels with coronary 
aneurysms. This regression usually occurs within 
1 to 2 years after onset. Typical aneurysms which 
tend to regress are small or medium aneurysms, 
fusiform aneurysm and distal coronary segment 
aneurysms.21 Despite completely regress, such 
patients still need follow-up because coronary 
artery stenosis, coronary diastolic dysfunction 
and intimal hyperplasia may develop which 
lead to juvenile arteriosclerosis and myocardial 
ischemia.13 (2) Occlusion: coronary artery 
occlusion develops early in less than 1% of 
cases, typically in giant aneurysms.20 Total 
coronary occlusion can develop acute myocardial 
infarction which greatly contributes to mortality 
of Kawasaki disease in children. Occlusion of 
aneurysms can occur because of flow stagnation 
and the sudden reduction of shear stress in 
the aneurysm.22 Occlusion happen in early 
phase can be caused by jelly-like extracellular 
matrix which formed plug in the vasculitis 
site or thrombus plug in aneurysms.23 Intimal 
fibroblastic proliferation with superimposed 
thrombosis has also been observed.24 (3) 
Occlusion with recanalization: Recanalization of 
coronary occlusion is typical of Kawasaki disease 
and give rise to neovascularization and collateral 
flow which rescue myocardia from infarcted.22 
About 15% of Kawasaki disease develops this 
recanalization or segmental stenosis which 
frequently (about 90%) occurs in right coronary 
artery.13 (4) Localized stenosis: localized stenosis 
develops in about 10% in acute Kawasaki 
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disease.20 Most of the localized stenosis occurs 
in the inlet and/or outlet of aneurysms, the site 
of high shear stress.22 Shear stress promotes 
endothelial cell injury which induces intimal 
thickening and muscular proliferation lead to 
stenosis. During the period of up to 10 to 21 
years after onset, localized stenosis of more than 
75% vessel diameter develop in 4.7 to 12% of 
patients with coronary artery lesions and mainly 
occurs in the proximal segment of left anterior 
descending artery.13
In the late phase of disease, several years 
after acute phase subsided, coronary aneurysms 
will undergo regression, rupture, extention, 
calcification, occlusion, occlusion with 
recanalization or collateral vessels and localized 
stenosis.20 Active remodeling of coronary artery 
lesions of Kawasaki disease are still taking place 
many years later, characterized by coronary 
artery intimal proliferation and various degrees 
of angiogenesis which were evident in autopsy 
pathology.23 Regression of coronary artery 
aneurysms may be because of true healing 
or masquerading by intimal proliferation 
and thrombus organization, or arterial wall 
contraction due to scar formation which narrow 
coronary lumen.3 Intravascular ultrasound study 
in the regressed coronary aneurysms shows 
marked symmetrical or asymmetrical myointimal 
thickening25 and plaque area with various degrees 
of fibrous, fibrofatty changes, superficial dense 
calcium, and necrotic core components.26
Fibrous scar formation or calcification 
possibly develops in aneurysms years later.23 
Arterial wall calcification in the site of aneurysms 
or former aneurysms are pathognomonic sign 
of Kawasaki disease in later life.18 In a report 
of Japanese young adults 20 years later after 
acute phase of Kawasaki disease, 94% of 
those with aneurysms at least 6 mm in internal 
diameter during the sub acute phase of the 
illness had calcification observed by electron 
beam computed tomography.27 Calcification 
of Kawasaki disease differs from that of 
atherosclerotic calcification which tends to be 
localized in the pre-existing aneurysms site not 
diffuse calcification. Calcification in Kawasaki 
disease reflected the degree of acute vasculitis 
and subsequent intimal proliferation which 
localized in proximal coronary segment and 
rarely involve the small branches and peripheral 
coronary arteries.28 Localized proximal coronary 
calcification can be detected with cardiac X-ray 
and may help identify patients with Kawasaki 
disease.28
Coronary artery lesions characteristic of 
Kawasaki disease observed in adult life include 
giant aneurysms, coronary artery calcification, 
segmental stenosis with recanalization after 
thrombotic occlusion and aneurysms involving 
the left coronary artery bifurcation.28 Angiography 
finding shows that coronary artery lesions of 
Kawasaki disease usually involve the proximal 
segments of the major branches, left anterior 
descending and right coronary arteries, and 
tend to be localized.29 This nature consequently 
contributes to high possibility to develop acute 
coronary syndrome once the lesions become 
significant stenotic or thrombus occlusion.
Besides coronary artery aneurysms and 
stenosis, coronary artery of Kawasaki disease 
shows various degree of coronary artery 
dysfunction. Dilatation capacity, endothelial 
dependent or endothelial independent, and 
coronary-myocardial blood flow reserve are 
impaired, even in those with angiographycaly 
normal coronary artery.18 Carotid artery intimal 
medial thickness (IMT) is increased in patients 
affected with Kawasaki disease, especially in those 
with coronary artery aneurysms.30 Decreases of 
arterial compliance and distensibility, increases 
in aortic root size, increases in myocardial 
fibrosis, and alterations in the coronary artery 
microvasculature have been reported, although 
in relatively small population.7 Persistence of 
vascular inflammation and increased oxidative 
stress was observed.31 The clinical consequence 
of these findings is undetermined for patients 
without coronary artery lesion,  although for those 
with persistent or regressed aneurysms, these 
findings indicate an increased risk of accelerated 
atherosclerosis, ventricular dysrhythmias, and 
ischemic cardiomyopathy.7 Progressive localized 
stenosis at the site of regressed aneurysm is often 
observed in the late phase of Kawasaki disease. 
Even an angiographically normal coronary artery 
may developed intimal thickening, leading to 
accelerated atherosclerosis and premature cardiac 
events.30 Coronary arteries of Kawasaki disease 
patients predispose to accelerated atherosclerosis 
and contribute to coronary heart disease in 
relatively young ages.13,18,21
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ACUTE CORONARY SYNDROME IN ADULT 
WITH SEQUEL OF KAWASAKI DISEASE
The growing number of adults with coronary 
artery lesions caused by Kawasaki disease 
is expected after 40 years passed since first 
description of this disease. Some of them have 
been diagnosed with Kawasaki disease in the 
childhood and survive into adult life, some 
others not known until unexpected cardiac event 
occurs. Acute coronary syndrome occurring 
in adults affected with Kawasaki disease’s 
coronary artery lesions happen at a younger age 
than acute coronary syndrome in the general 
population. Other cardiovascular risk factors 
in this population were lower than common 
atherosclerotic acute coronary syndrome.29
In the Kawasaki disease patients, the specific 
nature of the Kawasaki disease-related lesions 
seems to strongly influence the onset of acute 
coronary syndrome rather than the atherosclerotic 
risk factors.29 Accelerated atherosclerosis in affected 
coronary artery is responsible for development 
acute coronary syndrome. Atherosclerosis of 
patient affected with Kawasaki disease greatly 
differ histologically from that of common 
atherosclerosis.13,18 Autopsy result of patients 
who died late after Kawasaki disease revealed 
calcified aneurysms, myointimal proliferation, and 
organizing thrombus in the coronary arteries with 
recanalization, whereas lipid-laden macrophages 
and cholesterol crystals, the hallmarks of common 
atherosclerosis were lack.32
This young adult population with no known 
previous cardiovascular history and a few 
cardiovascular risk factors may present with 
angina pectoris, myocardial infarction, ischemia-
induced arrhythmia, or even sudden death.18,21 
Coronary angiography should be done early 
and the finding of the coronary arteries with 
proximal aneurysms with or without calcification 
followed by an angiographically normal distal 
segment should prompt anamnesis about history 
of Kawasaki disease in childhood.18,33
Tsuda et al.29 evaluated 50 cases of acute 
coronary syndrome in adult patients affected 
with Kawasaki disease. They found that giant 
calcified aneurysms in the proximal part of the 
major branches of coronary artery were the most 
common culprit lesions. Thrombus formation 
within the aneurysm precipitated the development 
of acute coronary syndrome. They also suggested 
that even if the aneurysms underwent regression, 
the risk of acute coronary syndrome remains in 
adult life of Kawasaki disease.
JCS working group13 recommend that 
Kawasaki disease patients with angina pectoris, 
myocardial infarction, heart failure, or severe 
arrhythmia in adult life should be followed in 
the same way as patients with such conditions 
associated with etiologies other than Kawasaki 
disease. It is advised that patients should be 
evaluated with noninvasive techniques, such 
as exercise ECG, exercise or pharmacological 
stress myocardial scintigraphy, Holter ECG, 
echocardiography, magnetic resonance coronary 
angiography (MRCA) or multislice 3D-computed 
tomography (MDCT) coronary angiography, 3 
to 4 times each year and coronary arteriography 
as appropriate.
CONCLUSION
Young adults suffered from acute cardiac 
event, such as acute coronary syndrome, 
ischemic-associated arrhythmia and sudden 
death, are frequently encountered without known 
etiology. Coronary vasculitis due to Kawasaki 
disease contributes to be a risk factor in young 
adult population to develop acute coronary event. 
Sequel of Kawasaki disease of childhood is rarely 
recognized by internist and adult cardiologists 
due to lack of information in childhood medical 
history or undiagnosed Kawasaki disease. Better 
understanding of the natural history of Kawasaki 
disease sequel, in particular coronary artery 
lesions, is necessary to detect those at risk and 
prevent further complication.
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